July 24, 2014 4:44 PM ET

Biotechnology

Company Overview of Nucleonics, Inc.

Company Overview

Nucleonics, Inc., a biotechnology company, develops RNAi therapeutics for viral and other diseases. It offers NUC-B1000, a hepatitis B antiviral agent. The company also focuses on the development of eiRNA-based therapeutics for chronic hepatitis B and hepatitis C infections. Nucleonics, Inc. was founded in 2001 and is based in Langhorne, Pennsylvania.

13 Summit Square Center

Suite 305

Langhorne, PA 19047-1098

United States

Founded in 2001

Phone:

267-518-0100

Fax:

267-518-0054

Key Executives for Nucleonics, Inc.

Chief Executive Officer
Age: 62
Vice President of Finance & Administration
Age: 51
Senior Vice President of Research & Development
Chief Medical Officer
Age: 74
Vice President of Preclinical Reasearch
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
ImmunePath, Inc. United States
Genovel Orthopedics, Inc. United States
Expert BioMed, Inc. United States
Mira Dx, Inc. United States
LaserGen, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Nucleonics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.